ZELIRA THERAPEUTICS LIMITED

0.00%

41.0¢

Market Cap $4.877M

Healthcare Biotechnology

Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company... Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. It owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. It is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription (Rx) business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter (OTC) products. It has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The Company in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.More

HELPING PATIENTS ON THEIR JOURNEY TO BETTER HEALTH

Little Green Pharma (ASX:LGP) to benefit as Denmark commits to cannabis pilot program.

Latest Threads

Tag

Subject

ZLD

Ann: Quarterly Activities/Appendix 4C Cash Flow Report

30/07/25

317

30/07/25

Last post hotmumbo

317

ZLD

Ann: Quarterly Activities/Appendix 4C Cash Flow Report

30/07/25

3.3K

30/07/25

Last post FiSaver

3.3K

ZLD

Ann: Zelira Therapeutics Secures R&D Loan Facility

24/07/25

547

24/07/25

Last post wgly

547

ZLD

Ann: Publication of ZLT-L-007 IRB Approved Observational Study

23/05/25

2.3K

23/05/25

Last post FiSaver

2.3K

ZLD

Ann: Full Conversion of $USD3.25M Convertible Notes in HOPE SPV

28/04/25

357

28/04/25

Last post

ASX News

357

ZLD

Ann: Investor Presentation

03/04/25

474

03/04/25

Last post

ASX News

474

ZLD

Ann: Application for quotation of securities - ZLD

01/04/25

280

01/04/25

Last post

ASX News

280

ZLD

Ann: Cleansing Prospectus

13:27

314

13:27

Last post

ASX News

314

See All Discussions

Timeline

Quarterly Activities/Appendix 4C Cash Flow Report
30 Jul 16:29	Share

Zelira Therapeutics Secures R&D Loan Facility
24 Jul 12:05	Share

Publication of ZLT-L-007 IRB Approved Observational Study
22 May 08:21	Share

Quarterly Activities/Appendix 4C Cash Flow Report
29 Apr 11:06	Share

Full Conversion of $USD3.25M Convertible Notes in HOPE SPV
28 Apr 08:23	Share

Investor Presentation
03 Apr 08:17	Share

Application for quotation of securities - ZLD
01 Apr 17:49	Share

Cleansing Prospectus
31 Mar 13:07	Share

Proposed issue of securities - ZLD
31 Mar 12:33	Share

Zelira secures $1 Million At-the-Market Funding Facility
31 Mar 08:18	Share

Appendix 4D & FY25 Interim Financial Report
26 Feb 20:14	Share

Zelira receives $1,153,000 R&D Tax Incentive Scheme Refund
18 Feb 13:32	Share

Quarterly Activities/Appendix 4C Cash Flow Report
30 Jan 14:08	Share

Zeliras HOPE SPV Secures US$681,000 Fourth Funding Tranche
28 Jan 08:25	Share

Change of Director's Interest Notice x 2
20 Jan 20:13	Share

Notification of cessation of securities - ZLD
17 Jan 17:19	Share

Change of Director's Interest Notice
19 Dec 17:55	Share

Notification regarding unquoted securities - ZLD
18 Dec 13:15	Share

Zelira to present at Automic Invest 2024 conference
20 Nov 08:51	Share

Proposed issue of securities - ZLD
14 Nov 17:34	Share

Results of Meeting
14 Nov 12:47	Share

2024 Annual General Meeting Presentation
14 Nov 11:02	Share

Appendix 4C Cash Flow Report
29 Oct 12:39	Share

September 2024 Quarterly Activities Report
29 Oct 12:39	Share

Letter to Shareholders
11 Oct 15:52	Share

Notice of Annual General Meeting/Proxy Form
11 Oct 15:51	Share

Investor Webinar - HOPE FDA Program Update
20 Sep 10:42	Share

Notice of Investor Webinar - HOPE FDA Program Update
18 Sep 08:18	Share

AGM Date and Closing Date for Director Nominations
12 Sep 16:54	Share

Appendix 4G
28 Aug 13:35	Share

View More

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 41.0¢		Change 0.000(0.00%)		Mkt cap ! $4.877M

Open	High	Low	Value	Volume
41.0¢	41.0¢	41.0¢	$1.265K	3.086K

Buyers (Bids)

No.	Vol.	Price($)
3	4176	41.0¢

Sellers (Offers)

Price($)	Vol.	No.
44.0¢	58	1

View Market Depth

No.	Vol.	Price($)
3	4176	0.410
1	625	0.400
1	500	0.380
2	8000	0.350
0	0	0.000

Price($)	Vol.	No.
0.440	58	1
0.450	429	1
0.460	2758	3
0.470	1304	1
0.500	5474	4

Last trade - 12.19pm 31/07/2025 (20 minute delay)

ZLD (ASX) Chart

ZELIRA THERAPEUTICS LIMITED

Latest Threads

Timeline

Featured News

Latest Videos

Zelira Therapeutics (ASX:ZLD) raises $1.77m through US-based investors

15 Mar 2023 14:06 (AEDT)

Latest Articles

Zelira Therapeutics (ASX:ZLD) promotes Greg Blake as Executive Director

Zelira Therapeutics (ASX:ZLD) has promoted Greg Blake from VP - Global Head ofCommercial and Partnering to Executive Director.

Zelira Therapeutics (ASX:ZLD) secures US$8.6m in funding for HOPE clinical trials

Zelira Therapeutics (ASX:ZLD) has secured US$8.6 million (A$12.3 million) in cornerstone funding from a US-based investor to support its HOPE clinical trials.

Buyers (Bids)

Sellers (Offers)

Infini Resources appoints Rohan Bone as CEO ahead of Phase 2 campaign

Resolution Minerals appoints industry experts to fast-track US growth strategy

A new NASDAQ listing for a key player in the global critical minerals space

Top Stories

Featured News